Universe Pharmaceuticals (UPC) Intangibles (2020 - 2025)

Universe Pharmaceuticals has disclosed Intangibles across 6 years of filings, most recently posting $473.9 million for Q3 2025.

• Intangibles for Q3 2025 came in at $473.9 million, up 80.29% year-over-year; the trailing twelve-month figure through Sep 2025 was $473.9 million (up 80.29% YoY), and the FY2025 annual result was $473.9 million, up 80.29% from the prior year.
• Intangibles came in at $473.9 million for Q3 2025 at Universe Pharmaceuticals, up from $262.9 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $473.9 million in Q3 2025 to a low of $147652.0 in Q1 2024.
• The 5-year median for Intangibles is $222942.5 (2022), against an average of $92.2 million.
• Across the five-year window, Intangibles plunged 100.0% in 2021 and soared 98311.58% in 2024, its largest moves.
• Universe Pharmaceuticals' Intangibles stood at $148584.0 in 2021, then jumped by 84.39% to $273974.0 in 2022, then dropped by 2.5% to $267121.0 in 2023, then jumped by 98311.58% to $262.9 million in 2024, then jumped by 80.29% to $473.9 million in 2025.
• The last three Intangibles figures came in at $473.9 million (Q3 2025), $262.9 million (Q3 2024), and $147652.0 (Q1 2024), per Business Quant data.